Use of ethyl esters of tryptophan to bypass the absorption defect in Hartnup disease.
D004305:Dose-Response Relationship, Drug; D006250:Hartnup Disease / Q000188:drug therapy*; D006801:Humans; D014364:Tryptophan / Q000031:analogs & derivatives* / Q000627:therapeutic use
C025166:tryptophan ethyl ester; D014364:Tryptophan